Illumina Reports Flat Revenues in Q3 | GenomeWeb

SAN FRANCISCO, Nov. 8 – Illumina on Thursday posted third-quarter revenues of $700,000, unchanged from the same quarter a year ago, the company announced.

San Diego-based Illumina reported a net loss of $5.8 million, or 19 cents per share for the third quarter of 2001, compared to a net loss of $3.9 million, or 15 cents per share for the third quarter of 2000. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.